The potential impact of the COVID-19 pandemic on global antimicrobial and biocide resistance : an AMR Insights global perspective
dc.contributor.author | Ansari, Shamshul | |
dc.contributor.author | Hays, John P. | |
dc.contributor.author | Kemp, Andrew | |
dc.contributor.author | Okechukwu, Raymond | |
dc.contributor.author | Murugaiyan, Jayaseelan | |
dc.contributor.author | Ekwanzala, Mutshiene Deogratias | |
dc.contributor.author | Ruiz Alvare, Maria Josefina | |
dc.contributor.author | Paul-Satyaseela, Maneesh | |
dc.contributor.author | Iwu, Chidozie Declan | |
dc.contributor.author | Balleste-Delpierre, Clara | |
dc.contributor.author | Septimus, Ed | |
dc.contributor.author | Mugisha, Lawrence | |
dc.contributor.author | Fadare, Joseph | |
dc.contributor.author | Chaudhuri, Susmita | |
dc.contributor.author | Chibabhai, Vindana | |
dc.contributor.author | Wadanamby, J.M. Rohini W.W. | |
dc.contributor.author | Daoud, Ziad | |
dc.contributor.author | Xiao, Yonghong | |
dc.contributor.author | Parkunan, Thulasiraman | |
dc.contributor.author | Khalaf, Yara | |
dc.contributor.author | Van Dongen, Maarten B. M. | |
dc.contributor.author | Barkema, Herman W. | |
dc.contributor.author | Strathdee, Steffanie | |
dc.contributor.author | Benyeogor, Emmanuel | |
dc.contributor.author | Ighodalo, Uzairue Leonard | |
dc.contributor.author | Prasad, Kurcheti Pani | |
dc.contributor.author | M., Carlos | |
dc.contributor.author | Gu, Yoshiaki | |
dc.contributor.author | Essack, Sabiha | |
dc.contributor.author | De Silva, Dilan | |
dc.contributor.author | Vellinga, Akke | |
dc.contributor.author | Ghannam, Wagih Mommtaz | |
dc.contributor.author | Tsoho, Najib Auwal | |
dc.contributor.author | Sakeena, M.H.F. | |
dc.contributor.author | Ilenwabor, Rhoda | |
dc.contributor.author | Shetty, Dhanuraj (Raj) | |
dc.contributor.author | Ayebare, Arnold | |
dc.contributor.author | Traore, Zoumana Isaa | |
dc.contributor.author | Henry, Ola | |
dc.contributor.author | Kiran, Amritanjali | |
dc.contributor.author | Ilenwabor, Rhoda | |
dc.contributor.author | Toro, Luisa Fernanda | |
dc.contributor.author | Smail, Adil | |
dc.contributor.author | Amulele, Anne | |
dc.contributor.author | Founou, Luria Leslie | |
dc.contributor.author | Sawant, Prathamesh S. | |
dc.contributor.author | Buregyeya, Esther | |
dc.contributor.author | Castro-Sanchez, Enrique | |
dc.contributor.author | Moreno-Morales, Javier | |
dc.contributor.author | Izadjoo, Mina | |
dc.contributor.author | Gori, Andrea | |
dc.contributor.author | Goff, Debra | |
dc.contributor.author | Blocker, Arielle | |
dc.contributor.author | Forte, Giovanna | |
dc.contributor.author | Tahir, Muhammad Farooq | |
dc.contributor.author | Diggle, Mathew | |
dc.contributor.author | Chakraborty, Dipanjan | |
dc.contributor.author | Asamoah, Anita E. | |
dc.contributor.author | Humphrey Aberi | |
dc.date.accessioned | 2022-08-30T11:35:03Z | |
dc.date.available | 2022-08-30T11:35:03Z | |
dc.date.issued | 2021-06 | |
dc.description.abstract | The COVID-19 pandemic presents a serious public health challenge in all countries. However, repercussions of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections on future global health are still being investigated, including the pandemic’s potential effect on the emergence and spread of global antimicrobial resistance (AMR). Critically ill COVID-19 patients may develop severe complications, which may predispose patients to infection with nosocomial bacterial and/or fungal pathogens, requiring the extensive use of antibiotics. However, antibiotics may also be inappropriately used in milder cases of COVID-19 infection. Further, concerns such as increased biocide use, antimicrobial stewardship/infection control, AMR awareness, the need for diagnostics (including rapid and point-of-care diagnostics) and the usefulness of vaccination could all be components shaping the influence of the COVID-19 pandemic. In this publication, the authors present a brief overview of the COVID-19 pandemic and associated issues that could influence the pandemic’s effect on global AMR. | en_US |
dc.description.department | School of Health Systems and Public Health (SHSPH) | en_US |
dc.description.librarian | am2022 | en_US |
dc.description.sponsorship | This study was supported by internal funding. | en_US |
dc.description.uri | https://academic.oup.com/jacamr | en_US |
dc.identifier.citation | Ansari, S., Hays, J.P., Kemp, A. et al. 2021, 'The potential impact of the COVID-19 pandemic on global antimicrobial and biocide resistance : an AMR Insights global perspective', JAC-Antimicrobial Resistance, vol. 3, no. 3, pp. 1-12, doi : 10.1093/jacamr/dlab038. | en_US |
dc.identifier.issn | 2632-1823 | |
dc.identifier.other | 10.1093/jacamr/dlab038 | |
dc.identifier.uri | https://repository.up.ac.za/handle/2263/87003 | |
dc.language.iso | fr | en_US |
dc.publisher | Oxford University Press | en_US |
dc.rights | © The Author(s) 2021. This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License. | en_US |
dc.subject | Impact | en_US |
dc.subject | Challenge | en_US |
dc.subject | COVID-19 pandemic | en_US |
dc.subject | Coronavirus disease 2019 (COVID-19) | en_US |
dc.subject | Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) | en_US |
dc.subject | Antimicrobial resistance (AMR) | en_US |
dc.subject | Biocide resistance | en_US |
dc.title | The potential impact of the COVID-19 pandemic on global antimicrobial and biocide resistance : an AMR Insights global perspective | en_US |
dc.type | Article | en_US |